Manganese Sulfate

CHEMBL2103742 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
151.0 g/mol
LogP
Phase
4

A sulfate salt form of manganese used as a trace mineral supplement in parenteral nutrition and to treat manganese deficiency, supporting normal bone development and metabolic processes.

Moleküler Ağırlık

151,0000 g/mol

TPSA

88,60 Ų

Terapötik Alanlar

Etki Mekanizması

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[O-]S(=O)(=O)[O-].[Mn+2]

InChI

InChI=1S/Mn.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2

Molecular Formula

MnO4S

HBD / HBA

- / 4

Döndürülebilir Bağlar

0

Ağır Atomlar

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A sulfate salt form of manganese used as a trace mineral supplement in parenteral nutrition and to treat manganese deficiency, supporting normal bone development and metabolic processes.

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Yes, Manganese Sulfate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2103742. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24580. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.